![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
20
Shandong Anhong Pharmaceutical Co., Ltd. Dezhou City Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Sorafenib tosilate, Micronised, polymorphic form I, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2023-250 - Rev 01
This Chemical Type CEP, issued on December 20, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2931 associated with this CEP further emphasizes